Onconic Therapeutics Inc. Logo

Onconic Therapeutics Inc.

Biopharmaceutical company developing drugs for cancer and gastrointestinal disorders.

476060 | KO

Overview

Corporate Details

ISIN(s):
KR7476060009
LEI:
Country:
South Korea
Address:
서울특별시 강남구 테헤란로26길 12 제일비젼타워 11층, 강남구

Description

Onconic Therapeutics Inc., established in 2020, is a biopharmaceutical company specializing in the research and development of innovative drugs. A subsidiary of Jeil Pharmaceutical, the company focuses on creating novel treatments for cancer and gastrointestinal disorders, including gastroesophageal reflux disease. Its development strategy prioritizes therapeutics for conditions with high unmet medical needs and significant market potential. Onconic Therapeutics actively advances its pipeline of drug candidates through various stages of clinical trials.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-03-07 00:00
주주총회소집공고
Korean 93.6 KB
2025-02-17 00:00
주주총회소집결의
Korean 6.8 KB
2025-02-07 00:00
매출액또는손익구조30%(대규모법인은15%)이상변동
Korean 11.7 KB
2025-02-06 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 21.6 KB
2025-02-06 00:00
주식등의대량보유상황보고서(약식)
Korean 59.6 KB
2025-01-24 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 21.5 KB
2025-01-23 00:00
투자판단관련주요경영사항 (국산신약 37호 자큐보정의 품목허가사항 변경허가 신청(위궤양 신규적응증 추가를 위한 한국 식품…
Korean 10.4 KB
2024-12-27 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 21.8 KB
2024-12-23 00:00
투자판단관련주요경영사항 (파트너사인 Livzon Pharmaceutical Group Inc.의 Zastaprazan(…
Korean 9.8 KB
2024-12-23 00:00
주식등의대량보유상황보고서(약식)
Korean 64.0 KB
2024-12-23 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 22.1 KB
2024-12-23 00:00
주식등의대량보유상황보고서(일반)
Korean 111.0 KB
2024-12-23 00:00
[기재정정]주식등의대량보유상황보고서(약식)
Korean 66.2 KB
2024-12-20 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 21.8 KB
2024-12-20 00:00
주식등의대량보유상황보고서(약식)
Korean 54.8 KB

Automate Your Workflow. Get a real-time feed of all Onconic Therapeutics Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Onconic Therapeutics Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Onconic Therapeutics Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.